Z-1517-2017 Class II Terminated
FDA device recall Z-1517-2017 was initiated by Merge Healthcare, Inc. on Sep 22, 2015 and is designated Class II. Reason for recall: Users can merge a device import file with an image study that already has a confirmed report, which may result in including information not present at the time of physician interpretation. The recall status is terminated (terminated Aug 8, 2019). Affected quantity: 89 sites potentially have the affected software.
Recall details
- Product Type
- Devices
- Report Date
- Mar 29, 2017
- Initiation Date
- Sep 22, 2015
- Termination Date
- Aug 8, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 89 sites potentially have the affected software
Product description
Merge Cardio software. Product Usage: Merge Cardio is a system intended to be used to acquire, store, print, transfer, and archive clinical information including images, Hemodynamic studies and reports, measurements (via import from DICOM Structured Reporting, text files or optical character recognition of measurements captured on images) and cardiology signal (waveform) data.
Reason for recall
Users can merge a device import file with an image study that already has a confirmed report, which may result in including information not present at the time of physician interpretation.
Distribution pattern
US Nationwide Distribution.
Code information
Versions 9.0, 9.0.1, 9.0.2, 9.0.3, 9.0.4, 9.0.5, 9.0.6, 9.0.7, and 9.0.8
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1517-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026